JENNIFER WANGLER: Open Payments
NPI 1750573838 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$367 in 17 payments from 6 companies in 2025. Trend: 2023 $264 · 2024 $382 · 2025 $367
Food & beverage: $367
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $151 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $103 |
| Exact Sciences Corporation | 2 | $43 |
| Ardelyx, Inc. | 2 | $28 |
| Phathom Pharmaceuticals, Inc. | 2 | $25 |
| Amgen Inc. | 1 | $17 |
Products named: DUPIXENT, ENTYVIO, IBSRELA, VOQUEZNA, The Cologuard Plus Collection Kit, Cologuard Collection Kit, UPLIZNA, EOHILIA.
Industry payments across FL — which companies pay providers there.
